HIV-AIDS

New design revealed for Palm Springs AIDS memorial following 2023 controversy - Desert Sun

Thu, 09/12/2024 - 19:10

AIDS/LifeCycle to end annual fundraising ride after 3 decades - San Francisco Chronicle

Thu, 09/12/2024 - 19:01

HIV services discontinued at Minneapolis housing complex - KSTP

Thu, 09/12/2024 - 18:59

Gilead Stock Rises on Positive Study Results for Twice-Yearly HIV Drug - The Wall Street Journal

Thu, 09/12/2024 - 18:50

Lil Kim To Headline The 33rd Annual AIDS Walk Atlanta Music Festival - CelebrityAccess ENCORE

Thu, 09/12/2024 - 18:16

Lil Kim To Headline The 33rd Annual AIDS Walk Atlanta Music Festival - CelebrityAccess ENCORE

Thu, 09/12/2024 - 18:16

Biden-Harris Administration Issues Proposed Rule to Expand Access to Life-Saving Organs for People with HIV - HIV.gov

Thu, 09/12/2024 - 17:15

Failing to Meet Global Targets Means 17.7 Million More AIDS-Related Deaths - Pharmacy Practice News

Thu, 09/12/2024 - 16:20

Twice-yearly injections prevent HIV in another phase 3 trial - Healio

Thu, 09/12/2024 - 15:39

Nebraska campaign targets HIV awareness with testing and education - KNOP

Thu, 09/12/2024 - 15:21

Nebraska campaign targets HIV awareness with testing and education - KNOP

Thu, 09/12/2024 - 15:21

USCHA: A Note From Paul - POZ

Thu, 09/12/2024 - 14:47

Spotted: GAIA’s Joyce Jere with former Warrior Festus Ezeli - InMenlo

Thu, 09/12/2024 - 14:45

Palm Springs AIDS Memorial Task Force Shares New Memorial Design - Palm Springs Tribune

Thu, 09/12/2024 - 14:19

Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access? - U.S. News & World Report

Thu, 09/12/2024 - 13:49

Twice-yearly injection reduced HIV infections by 96 percent, company says - The Hill

Thu, 09/12/2024 - 13:21

Gilead Stock Rises on Positive Study Results for Twice-Yearly HIV Drug - The Wall Street Journal

Thu, 09/12/2024 - 13:13

Triple antibody therapy shows promise for long-lasting HIV control - Medical Xpress

Thu, 09/12/2024 - 13:12

National HIV/AIDS Strategy Quality of Life Goals Unlikely to Be Met - AJMC.com Managed Markets Network

Thu, 09/12/2024 - 13:03

PUBLIC HEALTH CORNER: National HIV/AIDs & Aging Awareness Day - Kirksville Daily Express and Daily News

Thu, 09/12/2024 - 13:00

Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access? - The Mountaineer

Thu, 09/12/2024 - 12:45

Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access? - Wyoming Tribune

Thu, 09/12/2024 - 12:45

Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access? - NonStop Local Billings

Thu, 09/12/2024 - 12:45

Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access? - HealthDay

Thu, 09/12/2024 - 12:45

The Critical Role of Transportation in HIV Prevention and Treatment - JPHMP Direct

Thu, 09/12/2024 - 11:40

Amida Care’s HIV and LGBTQ Clients and Staff Want You to Vote! [VIDEOS] - POZ

Thu, 09/12/2024 - 10:32

Gilead’s Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV Infections by 96% and Demonstrated Superiority to Daily Truvada® in Second Pivotal Phase 3 Trial - BioSpace

Thu, 09/12/2024 - 10:18

Politics Causing Problem for Gen Z’s HIV Education – 2024 State of HIV Stigma Report - GLAAD

Thu, 09/12/2024 - 09:58

Methodology – 2024 State of HIV Stigma Report - GLAAD

Thu, 09/12/2024 - 09:56

Triple Antibody Therapy Shows Promise for Long-Las | Newswise - Newswise

Thu, 09/12/2024 - 09:05